ARCHIVES

Congressional Report Says NCI Ignored Das, Procedure, In Charges To Screening Guidelines

This article is from The Cancer Letter archive.

Vol. 20 No. 42 | November 4, 1994

Download PDF Visit The Full Archive

Related Articles

Amgen Halts Phase III Trial Of Ganitumab Plus Gemcitabine

August 31, 2012

In Brief: HHS Drags Feet, NCI Considering Contract To Review Cancer Research Facility Needs

October 14, 1983

Six More CCOPS In Funding Range For Recompetition

February 9, 1990

Hepatitis B Vaccine Almost Ready, Blumberg Tells Science Writers

April 10, 1981

Reaction To PSA Guideline Muffled Compared to 2009 Mammography Guideline

October 14, 2011

‘Approval to Apply’ For Proton Facility Upgrade Denied

February 24, 1989